Literature DB >> 11826022

Sensitivity of conformation sensitive gel electrophoresis in detecting mutations in Marfan syndrome and related conditions.

J Körkkö1, I Kaitila, L Lönnqvist, L Peltonen, L Ala-Kokko.   

Abstract

OBJECTIVE: It has been firmly established that mutations in the gene for fibrillin 1, FBN1, cause Marfan syndrome (MFS). FBN1 mutations can also cause other phenotypes, such as ectopia lentis (EL) and familial isolated thoracic aortic aneurysm and dissection (FAA). When the clinical presentation is typical, diagnosis of MFS is usually easy to make. However, there can be a marked phenotypic variation between affected subjects even in one family, and making the diagnosis can be challenging, especially in childhood. The objective of this study was to test the sensitivity of conformation sensitive gel electrophoresis (CSGE) for detecting mutations in FBN1 in MFS and related phenotypes.
DESIGN: Setting up CSGE analysis for the FBN1 gene and testing the method first by screening coded samples from 17 MFS patients with previously detected FBN1 mutations. We then used a test set consisting of 46 coded samples representing MFS, related phenotypes, and controls.
RESULTS: Sixteen of the 17 known mutations were detected. Altogether 23 mutations were detected in a test set consisting of 46 coded samples representing MFS, related phenotypes, and controls. Nineteen of the mutations were novel. The mutation was detected in 18 of the 20 MFS patients and in one patient with familial EL, but not in a patient with sporadic MASS syndrome, any of the five sporadic annuloaortic ectasia (AAE) patients, or any of the 15 controls. A FBN1 mutation was detected in four members of a multigeneration family with AAE, however.
CONCLUSIONS: These results indicate that CSGE is highly sensitive for the detection of mutations in FBN1, and that molecular diagnostics is a useful means of confirming clinical diagnoses of MFS and related disorders. Further careful investigations are needed, however, in order to correlate the interfamilial and intrafamilial clinical variabilities of fibrillinopathies and mutations in FBN1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11826022      PMCID: PMC1734965          DOI: 10.1136/jmg.39.1.34

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  17 in total

1.  Exon 47 skipping of fibrillin-1 leads preferentially to cardiovascular defects in patients with thoracic aortic aneurysms and dissections.

Authors:  Wen-Jing Wang; Peili Han; Jun Zheng; Fang-Yuan Hu; Yun Zhu; Jin-Sheng Xie; Jian Guo; Zhe Zhang; Jie Dong; Gu-Yan Zheng; Huiqing Cao; Tian-Shu Liu; Qinglin Fu; Lizhong Sun; Bi-Bo Yang; Xiao-Li Tian
Journal:  J Mol Med (Berl)       Date:  2012-07-08       Impact factor: 4.599

2.  FBN1 isoform expression varies in a tissue and development-specific fashion.

Authors:  Mary E Burchett; I-Fang Ling; Steven Estus
Journal:  Biochem Biophys Res Commun       Date:  2011-06-25       Impact factor: 3.575

Review 3.  The molecular genetics of Marfan syndrome and related disorders.

Authors:  P N Robinson; E Arteaga-Solis; C Baldock; G Collod-Béroud; P Booms; A De Paepe; H C Dietz; G Guo; P A Handford; D P Judge; C M Kielty; B Loeys; D M Milewicz; A Ney; F Ramirez; D P Reinhardt; K Tiedemann; P Whiteman; M Godfrey
Journal:  J Med Genet       Date:  2006-03-29       Impact factor: 6.318

4.  Identification of the minimal combination of clinical features in probands for efficient mutation detection in the FBN1 gene.

Authors:  Chantal Stheneur; Gwenaëlle Collod-Béroud; Laurence Faivre; Jean François Buyck; Laurent Gouya; Jean-Marie Le Parc; Bertrand Moura; Christine Muti; Bernard Grandchamp; Gilles Sultan; Mireille Claustres; Philippe Aegerter; Bertrand Chevallier; Guillaume Jondeau; Catherine Boileau
Journal:  Eur J Hum Genet       Date:  2009-03-18       Impact factor: 4.246

5.  Paucity of skeletal manifestations in Hispanic families with FBN1 mutations.

Authors:  Carlos Villamizar; Ellen S Regalado; Van Tran Fadulu; Sumera N Hasham; Prateek Gupta; Marcia C Willing; Shao-Qing Kuang; Dongchuan Guo; Ann Muilenburg; Richard W Yee; Yuxin Fan; Jeffrey Towbin; Joseph S Coselli; Scott A LeMaire; Dianna M Milewicz
Journal:  Eur J Med Genet       Date:  2009-11-23       Impact factor: 2.708

6.  Identification of FBN1 gene mutations in patients with ectopia lentis and marfanoid habitus.

Authors:  P Comeglio; A L Evans; G Brice; R J Cooling; A H Child
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

7.  Three novel mutations of the fibrillin-1 gene and ten single nucleotide polymorphisms of the fibrillin-3 gene in Marfan syndrome patients.

Authors:  Tomomi Uyeda; Toru Takahashi; Shuji Eto; Takumi Sato; Gang Xu; Rika Kanezaki; Tsutomu Toki; Susumu Yonesaka; Etsuro Ito
Journal:  J Hum Genet       Date:  2004-06-23       Impact factor: 3.172

8.  Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study.

Authors:  L Faivre; G Collod-Beroud; B L Loeys; A Child; C Binquet; E Gautier; B Callewaert; E Arbustini; K Mayer; M Arslan-Kirchner; A Kiotsekoglou; P Comeglio; N Marziliano; H C Dietz; D Halliday; C Beroud; C Bonithon-Kopp; M Claustres; C Muti; H Plauchu; P N Robinson; L C Adès; A Biggin; B Benetts; M Brett; K J Holman; J De Backer; P Coucke; U Francke; A De Paepe; G Jondeau; C Boileau
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

9.  A novel FBN1 missense mutation (p.C102Y) associated with ectopia lentis syndrome in a Chinese family.

Authors:  Yi Zhai; Wei Wang; Ya-Nan Zhu; Jin-Yu Li; Yin-Hui Yu; Kai-Ran Lai; Ke Yao
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

10.  Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events.

Authors:  Linnea M Baudhuin; Katrina E Kotzer; Susan A Lagerstedt
Journal:  Genet Med       Date:  2014-08-07       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.